| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $115.0M | +2.5% | -1.8% |
| Cost of Revenue | $12.5M | +4.6% | +1.1% |
| Gross Profit | $102.5M | +2.2% | -2.1% |
| R&D Expense | $30.9M | -3.9% | -8.5% |
| SG&A Expense | $16.7M | -0.5% | -13.6% |
| Operating Income | -$5.0M | +24.5% | -55.2% |
| Pre-tax Income | -$8.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $211.8M | +4.1% | -6.1% |
| Accounts Receivable | $24.9M | -3.5% | +2.3% |
| Current Assets | $449.8M | -2.2% | -17.4% |
| Total Assets | $573.6M | -3.2% | -12.0% |
| Current Liabilities | $75.3M | -10.1% | +2.5% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.2M | — | — |
| Capital Expenditures | $976K | — | — |
| Investing Cash Flow | $86.9M | — | — |
| Financing Cash Flow | -$96.7M | — | — |
| Free Cash Flow | $2.3M | — | — |
| +8.7% |
| -89.2% |
| Income Tax | $1.5M | +280.8% | +182.7% |
| Net Income | -$9.8M | -3.3% | -282.2% |
| EPS (Basic) | -$0.11 | -10.0% | -266.7% |
| EPS (Diluted) | -$0.11 | -10.0% | -266.7% |
| $544.5M |
| +0.1% |
| +0.2% |
| Total Liabilities | $649.7M | -1.3% | +1.8% |
| Stockholders' Equity | -$76.1M | -15.6% | -660.3% |